首页 > 最新文献

JACC. Asia最新文献

英文 中文
Interconnected Pathways and Therapeutic Implications for Cardiovascular Aging and Diseases. 心血管衰老和疾病的相互联系途径及其治疗意义。
Pub Date : 2025-12-04 DOI: 10.1016/j.jacasi.2025.10.017
Xiaoyuan Bai, Yiyuan Zhang, Jing Qu, Guang-Hui Liu

Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide, with their prevalence rising with advancing age. Progressive remodeling of the cardiovascular system during aging underlies increased vulnerability to cardiovascular pathologies. This review summarizes current insights into the structural, functional, and molecular hallmarks of both cardiovascular aging (CVA) and CVDs, highlighting their mechanistic convergence. By further discussing diagnostic biomarkers and intervention strategies that bridge these processes, we delineated the translational continuum linking CVA and CVDs. The understanding of their interconnections underscores the potential of targeting CVA as a strategy for CVD prevention, early diagnosis, and treatment.

心血管疾病(cvd)是世界范围内导致死亡的主要原因,其患病率随着年龄的增长而上升。在衰老过程中,心血管系统的进行性重塑是心血管疾病易感性增加的基础。本文综述了目前对心血管衰老(CVA)和cvd的结构、功能和分子特征的研究,并强调了它们的机制趋同。通过进一步讨论连接这些过程的诊断生物标志物和干预策略,我们描绘了连接CVA和cvd的转化连续体。对它们相互联系的理解强调了靶向CVA作为CVD预防、早期诊断和治疗策略的潜力。
{"title":"Interconnected Pathways and Therapeutic Implications for Cardiovascular Aging and Diseases.","authors":"Xiaoyuan Bai, Yiyuan Zhang, Jing Qu, Guang-Hui Liu","doi":"10.1016/j.jacasi.2025.10.017","DOIUrl":"https://doi.org/10.1016/j.jacasi.2025.10.017","url":null,"abstract":"<p><p>Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide, with their prevalence rising with advancing age. Progressive remodeling of the cardiovascular system during aging underlies increased vulnerability to cardiovascular pathologies. This review summarizes current insights into the structural, functional, and molecular hallmarks of both cardiovascular aging (CVA) and CVDs, highlighting their mechanistic convergence. By further discussing diagnostic biomarkers and intervention strategies that bridge these processes, we delineated the translational continuum linking CVA and CVDs. The understanding of their interconnections underscores the potential of targeting CVA as a strategy for CVD prevention, early diagnosis, and treatment.</p>","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-Term Outcomes of Cardiogenic Shock Treated With a Microaxial Flow Pump 微轴流泵治疗心源性休克的短期疗效
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.09.011
Shunsuke Matsushita MD, Yuichi Sawayama MD, PhD, Kohei Osakada MD, Shunsuke Kubo MD, Yuichi Kawase MD, Takeshi Tada MD, PhD, Yasushi Fuku MD, Hiroyuki Tanaka MD, Kazushige Kadota MD, PhD, the J-PVAD Investigators
{"title":"Short-Term Outcomes of Cardiogenic Shock Treated With a Microaxial Flow Pump","authors":"Shunsuke Matsushita MD,&nbsp;Yuichi Sawayama MD, PhD,&nbsp;Kohei Osakada MD,&nbsp;Shunsuke Kubo MD,&nbsp;Yuichi Kawase MD,&nbsp;Takeshi Tada MD, PhD,&nbsp;Yasushi Fuku MD,&nbsp;Hiroyuki Tanaka MD,&nbsp;Kazushige Kadota MD, PhD,&nbsp;the J-PVAD Investigators","doi":"10.1016/j.jacasi.2025.09.011","DOIUrl":"10.1016/j.jacasi.2025.09.011","url":null,"abstract":"","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Pages 1638-1641"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicenter Practice of Non/Minimized Fluoroscopy Ablation for Paroxysmal AF in China 中国非/最小化透视消融治疗阵发性房颤的多中心实践:PAF-ICE试验
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.07.011
Yunhe Wang MD , Deyong Long MD , Fangyi Xiao MD , Minglong Chen MD , Xingpeng Liu MD , Jidong Zhang MD , Yumei Xue MD , Jie Fan MD , Haixiong Wang MD , Mengzuo Wu MD , Rui Wang MD , Jia Li MD , Tao He MD , Weili Ge MD , Xiaobo Huang MD , Ruhong Jiang MD , Qiang Liu MD , Zuwen Zhang BS , Guosheng Fu MD , Chenyang Jiang MD

Background

Intracardiac echocardiography (ICE)-guided non/minimized-fluoroscopy catheter ablation for atrial fibrillation (AF) has been reported, but its effectiveness and safety still lack multicenter evidence.

Objectives

The authors sought to evaluate the effectiveness and safety of ICE-guided non/minimized-fluoroscopy catheter ablation compared with the traditional fluoroscopy-guided approach in patients with paroxysmal AF.

Methods

A total of 448 patients with paroxysmal AF, from 15 centers in China, were randomly assigned in a 1:1 ratio to a non/minimized-fluoroscopy group (n = 223) and a traditional approach group (n = 225). The primary efficacy endpoint was freedom from AF recurrence after a single ablation procedure. The primary safety endpoint was a composite of death from any cause, stroke or transient ischemic attack, and other serious adverse events.

Results

Pulmonary vein isolation was achieved in all patients. After a median follow-up of 12.2 (Q1-Q3: 8.8-17.7) months, 184 of 223 patients (82.5%) in the non/minimized-fluoroscopy group and 189 of 225 (84.0%) in the traditional approach group remained free from arrhythmia. Cox analysis showed a HR of 0.949 (95% CI: 0.774 to 1.164); P = 0.858, demonstrating the noninferiority of the non/minimized-fluoroscopy approach. The primary safety endpoint did not differ significantly in the 2 groups (P = 0.975). This protocol enabled near zero–radiation procedures (mean <1 mGy) in 7 of 15 centers (46.7%), and radiation-free AF ablation in 125 of 223 patients (56.1%), significantly reducing x-ray exposure and operator radiation protection equipment usage.

Conclusions

ICE-combined non/minimized-fluoroscopy AF ablation was noninferior in effectiveness compared to traditional AF ablation, with no significant difference in safety endpoints, indicating its potential of widespread adoption.
背景:心内超声心动图(ICE)引导下的非/最小化透视导管消融治疗房颤(AF)已有报道,但其有效性和安全性仍缺乏多中心证据。目的:作者试图评估ice引导下的非/最小化透视导管消融与传统透视入路治疗阵发性房颤的有效性和安全性。方法:来自中国15个中心的448例阵发性房颤患者,按1:1的比例随机分为非/最小化透视组(n = 223)和传统入路组(n = 225)。主要疗效终点是单次消融手术后房颤复发的自由。主要安全终点是任何原因导致的死亡、中风或短暂性脑缺血发作以及其他严重不良事件。结果:所有患者均获得肺静脉隔离。中位随访12.2 (Q1-Q3: 8.8-17.7)个月后,无/最小化透视组223例患者中184例(82.5%)和传统入路组225例患者中189例(84.0%)未出现心律失常。Cox分析显示HR为0.949 (95% CI: 0.774 ~ 1.164);P = 0.858,证明非/最小化透视入路的非劣效性。两组的主要安全终点无显著差异(P = 0.975)。结论:与传统的房颤消融相比,ice联合非/最小化透视房颤消融在有效性上并不逊色,在安全终点上没有显著差异,表明其广泛采用的潜力。
{"title":"Multicenter Practice of Non/Minimized Fluoroscopy Ablation for Paroxysmal AF in China","authors":"Yunhe Wang MD ,&nbsp;Deyong Long MD ,&nbsp;Fangyi Xiao MD ,&nbsp;Minglong Chen MD ,&nbsp;Xingpeng Liu MD ,&nbsp;Jidong Zhang MD ,&nbsp;Yumei Xue MD ,&nbsp;Jie Fan MD ,&nbsp;Haixiong Wang MD ,&nbsp;Mengzuo Wu MD ,&nbsp;Rui Wang MD ,&nbsp;Jia Li MD ,&nbsp;Tao He MD ,&nbsp;Weili Ge MD ,&nbsp;Xiaobo Huang MD ,&nbsp;Ruhong Jiang MD ,&nbsp;Qiang Liu MD ,&nbsp;Zuwen Zhang BS ,&nbsp;Guosheng Fu MD ,&nbsp;Chenyang Jiang MD","doi":"10.1016/j.jacasi.2025.07.011","DOIUrl":"10.1016/j.jacasi.2025.07.011","url":null,"abstract":"<div><h3>Background</h3><div>Intracardiac echocardiography (ICE)-guided non/minimized-fluoroscopy catheter ablation for atrial fibrillation (AF) has been reported, but its effectiveness and safety still lack multicenter evidence.</div></div><div><h3>Objectives</h3><div>The authors sought to evaluate the effectiveness and safety of ICE-guided non/minimized-fluoroscopy catheter ablation compared with the traditional fluoroscopy-guided approach in patients with paroxysmal AF.</div></div><div><h3>Methods</h3><div>A total of 448 patients with paroxysmal AF, from 15 centers in China, were randomly assigned in a 1:1 ratio to a non/minimized-fluoroscopy group (n = 223) and a traditional approach group (n = 225). The primary efficacy endpoint was freedom from AF recurrence after a single ablation procedure. The primary safety endpoint was a composite of death from any cause, stroke or transient ischemic attack, and other serious adverse events.</div></div><div><h3>Results</h3><div>Pulmonary vein isolation was achieved in all patients. After a median follow-up of 12.2 (Q1-Q3: 8.8-17.7) months, 184 of 223 patients (82.5%) in the non/minimized-fluoroscopy group and 189 of 225 (84.0%) in the traditional approach group remained free from arrhythmia. Cox analysis showed a HR of 0.949 (95% CI: 0.774 to 1.164); <em>P</em> = 0.858, demonstrating the noninferiority of the non/minimized-fluoroscopy approach. The primary safety endpoint did not differ significantly in the 2 groups (<em>P</em> = 0.975). This protocol enabled near zero–radiation procedures (mean &lt;1 mGy) in 7 of 15 centers (46.7%), and radiation-free AF ablation in 125 of 223 patients (56.1%), significantly reducing x-ray exposure and operator radiation protection equipment usage.</div></div><div><h3>Conclusions</h3><div>ICE-combined non/minimized-fluoroscopy AF ablation was noninferior in effectiveness compared to traditional AF ablation, with no significant difference in safety endpoints, indicating its potential of widespread adoption.</div></div>","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Pages 1540-1548"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145002136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discrepancies in Stroke Mortality Estimates 卒中死亡率估计的差异
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.10.002
Sukrit Treewaree MD , Natpatchara Pongjirapat MD , Rungroj Krittayaphong MD
{"title":"Discrepancies in Stroke Mortality Estimates","authors":"Sukrit Treewaree MD ,&nbsp;Natpatchara Pongjirapat MD ,&nbsp;Rungroj Krittayaphong MD","doi":"10.1016/j.jacasi.2025.10.002","DOIUrl":"10.1016/j.jacasi.2025.10.002","url":null,"abstract":"","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Pages 1628-1630"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transvenous Lead Extraction for Cardiac Implantable Electronic Device Infection 经静脉铅提取治疗心脏植入式电子装置感染
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.10.012
Nobuhiro Nishii MD, PhD
{"title":"Transvenous Lead Extraction for Cardiac Implantable Electronic Device Infection","authors":"Nobuhiro Nishii MD, PhD","doi":"10.1016/j.jacasi.2025.10.012","DOIUrl":"10.1016/j.jacasi.2025.10.012","url":null,"abstract":"","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Pages 1563-1565"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incremental Steps Toward the Holy Grail of Contemporary PCI 迈向当代PCI圣杯的渐进步骤:什么都不留下!
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.09.007
Martin W. Bergmann MD
{"title":"Incremental Steps Toward the Holy Grail of Contemporary PCI","authors":"Martin W. Bergmann MD","doi":"10.1016/j.jacasi.2025.09.007","DOIUrl":"10.1016/j.jacasi.2025.09.007","url":null,"abstract":"","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Pages 1587-1589"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subanalyses in HFmrEF Patients of Asian Ethnicity 亚洲族裔HFmrEF患者的亚分析
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.10.003
Xin Du MD
{"title":"Subanalyses in HFmrEF Patients of Asian Ethnicity","authors":"Xin Du MD","doi":"10.1016/j.jacasi.2025.10.003","DOIUrl":"10.1016/j.jacasi.2025.10.003","url":null,"abstract":"","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Pages 6-7"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological and Interpretive Limitations in the ABxFREE Trial ABxFREE试验的方法学和解释性局限性
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.10.010
Hakan Iskender MD , Alaeddin Acar MD
{"title":"Methodological and Interpretive Limitations in the ABxFREE Trial","authors":"Hakan Iskender MD ,&nbsp;Alaeddin Acar MD","doi":"10.1016/j.jacasi.2025.10.010","DOIUrl":"10.1016/j.jacasi.2025.10.010","url":null,"abstract":"","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Page 1650"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond BMI 除了体重指数
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.09.006
Wenjun Fan MD, PhD
{"title":"Beyond BMI","authors":"Wenjun Fan MD, PhD","doi":"10.1016/j.jacasi.2025.09.006","DOIUrl":"10.1016/j.jacasi.2025.09.006","url":null,"abstract":"","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Pages 1615-1617"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolated Thoracoscopic Left Atrial Appendage Occlusion Across 6 Centers 孤立性胸腔镜左心耳阻塞6个中心
Pub Date : 2025-12-01 DOI: 10.1016/j.jacasi.2025.09.009
Taisuke Nakayama MD, PhD , Hiroshi Ito MD, PhD , Shunsuke Sato MD , Seimei Go MD, PhD , Gentaku Hama MD , Masakazu Aoki MD , Shinya Takahashi MD, PhD
{"title":"Isolated Thoracoscopic Left Atrial Appendage Occlusion Across 6 Centers","authors":"Taisuke Nakayama MD, PhD ,&nbsp;Hiroshi Ito MD, PhD ,&nbsp;Shunsuke Sato MD ,&nbsp;Seimei Go MD, PhD ,&nbsp;Gentaku Hama MD ,&nbsp;Masakazu Aoki MD ,&nbsp;Shinya Takahashi MD, PhD","doi":"10.1016/j.jacasi.2025.09.009","DOIUrl":"10.1016/j.jacasi.2025.09.009","url":null,"abstract":"","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 12","pages":"Pages 1566-1568"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145651903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JACC. Asia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1